Citadel Advisors’s XORTX Therapeutics XRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.8K Buy
+38,468
New +$35.8K ﹤0.01% 5540
2024
Q3
Sell
-12,333
Closed -$23.3K 6832
2024
Q2
$23.3K Buy
+12,333
New +$23.3K ﹤0.01% 5371
2023
Q3
Sell
-347
Closed -$18.3K 6605
2023
Q2
$18.3K Buy
+347
New +$18.3K ﹤0.01% 5277
2023
Q1
Sell
-218
Closed -$14.7K 6646
2022
Q4
$14.7K Buy
+218
New +$14.7K ﹤0.01% 5608